Response to Letter RE: Impact of EDP-M on survival of patients with metastatic adrenocortical carcinoma: A population-based study.
- Resource Type
- Editorial & Opinion
- Authors
- Debets P; Amsterdam UMC location VU Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands.; Dreijerink KMA; Amsterdam UMC location VU Medical Center, Department of Endocrinology and Metabolism, Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands.; Engelsman A; Amsterdam UMC location VU Medical Center, Department of Surgery, Amsterdam, the Netherlands.; Dahele M; Amsterdam UMC location VU Medical Center, Department of Radiation Oncology and Cancer Center Amsterdam, Amsterdam, the Netherlands.; Haak HR; Maxima Medical Center, Department of Internal Medicine, Eindhoven, the Netherlands; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, the Netherlands; Department of Internal Medicine, Division of General Internal Medicine, Maastricht University Medical Centre+, Maastricht, the Netherlands.; Steenaard RV; Maxima Medical Center, Department of Internal Medicine, Eindhoven, the Netherlands; Maastricht University, CAPHRI School for Public Health and Primary Care, Ageing and Long-Term Care, Maastricht, the Netherlands; Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, the Netherlands.; Kapiteijn E; Leiden University Medical Center, Department of Medical Oncology, Leiden, the Netherlands.; Corssmit E; Amsterdam UMC location VU Medical Center, Department of Surgery, Amsterdam, the Netherlands; Leiden University Medical Center, Center of Endocrine Tumours, Division of Endocrinology, Department of Internal Medicine, Leiden, the Netherlands.; Menke-van der Houven van Oordt W; Amsterdam UMC location VU Medical Center, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, the Netherlands. Electronic address: c.menke@amsterdamumc.nl.
- Source
- Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
- Subject
- Language
- English
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial or personal relationships that could be of influence on the work reported in this paper. M. Dahele: Research grants and honorarium from Varian Medical Systems, outside the scope of this work.